Design and measurement of nonislet-specific autoantibodies for the type 1 diabetes genetics consortium autoantibody workshop

Diabetes Care

Volumn 38, Issue , 2015, Pages S4-S7

  Akolkar, Beena ^a   Hilner, Joan ^b   Nierras, Concepcion R ^c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c JDRF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; STEROID 21 MONOOXYGENASE; THYROID PEROXIDASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AUTOANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; IODIDE PEROXIDASE; IRON BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; TPO PROTEIN, HUMAN;

AUTOIMMUNE DISEASE; CONFERENCE PAPER; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; PHENOTYPE; PROTEIN EXPRESSION; QUALITY CONTROL; SIBLING; WORKSHOP; GENETIC ASSOCIATION STUDY; GENETICS; IMMUNOLOGY; METHODOLOGY; PROCEDURES; STANDARDS;

AUTOANTIBODIES; AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; GENETIC ASSOCIATION STUDIES; GTP-BINDING PROTEINS; HUMANS; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; QUALITY CONTROL; RESEARCH DESIGN; SODIUM-POTASSIUM-EXCHANGING ATPASE; STEROID 21-HYDROXYLASE; TRANSGLUTAMINASES;

EID: 84965188824     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dcs15-2002     Document Type: Conference Paper

References (12)

1. Hilner JE, Perdue LH, Sides EG, et al.; T1DGC. Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC). Clin Trials 2010;7(Suppl.):S5-S32
2. Rosinger S,Nutland S,Mickelson E, et al.; T1DGC. Collection and processing of whole blood for transformation of peripheral blood mononuclear cells and extraction ofDNA: the Type 1DiabetesGenetics Consortium. Clin Trials 2010;7(Suppl.):S65-S74
3. Perdue LH, Albret L, Aldrich A, et al.; T1DGC. Quality control of phenotypic forms data in the Type 1 Diabetes Genetics Consortium. Clin Trials 2010;7(Suppl.):S46-S55
4. Bingley PJ, Williams AJ, Colman PG, et al.; T1DGC. Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories. Clin Trials 2010;7(Suppl.):S56-S64
5. Wenzlau JM, Hutton JC. Novel diabetes autoantibodies and prediction of type 1 diabetes. Curr Diab Rep 2013;13:608-615
6. Concannon P, Erlich HA, Julier C, et al.; Type 1 Diabetes Genetics Consortium. Type 1 diabetes: evidence for susceptibility loci fromfour genomewide linkage scans in 1,435 multiplex families. Diabetes 2005;54:2995-3001
7. Concannon P, ChenWM, Julier C, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes 2009;58:1018-1022
8. Morahan G, Mehta M, James I, et al.; Type 1 Diabetes Genetics Consortium. Tests for genetic interactions in type 1 diabetes: linkage and stratification analyses of 4,422 affected sibpairs. Diabetes 2011;60:1030-1040
9. Barrett JC, Clayton DG, Concannon P, et al.; Type 1 Diabetes Genetics Consortium. Genomewide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-707
10. Onengut-Gumuscu S, Chen WM, Burren O, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet 2015;47:381-386
11. Brown WM, Pierce J, Hilner JE, et al.; Type 1 Diabetes Genetics Consortium. Overview of the MHC fine mapping data. Diabetes Obes Metab 2009;11(Suppl. 1):2-7
12. Brown WM, Pierce JJ, Hilner JE, et al.; Type I Diabetes Genetics Consortium. Overview of the Rapid Response data. Genes Immun 2009; 10(Suppl. 1):S5-S15